Cybermedlife - Therapeutic Actions Myofascial Release

Effects of the myofascial release in diffuse systemic sclerosis.

Abstract Title: Effects of the myofascial release in diffuse systemic sclerosis. Abstract Source: Acta Neurobiol Exp (Wars). 2010;70(2):177-86. PMID: 19761954 Abstract Author(s): Marilene Marfin Martin Abstract: OBJECTIVE: To improve breathing and functionality of the temporomandibular joint (TMJ) and hands, by increasing the range of motion (ROM), and to reduce the level of pain. METHOD: Twenty myofascial release (MR) sessions in 2002 with assessments (chest expansion, mouth opening, ROM of wrist and fingers). Between the 19th and the 20th session there was a break of 110 days. Every winter, 1-3 sessions have been made. RESULTS: Chest: expansion increased by 3.5 cm and pain was eliminated at the scar from a biopsy; TMJ: an 8mm increase in mouth opening with pain eliminated; hands and fingers: increase of ROM in all joints of fingers and wrists, of up to 100%, reduction in ulcerations and recovery of nail growth. CONCLUSION: The connective tissue affected by diffuse systemic sclerosis (dSSc) is subject to remodeling through MR, receding when the work is interrupted. Resuming the treatment on a regular basis increased the ROM in joints, reduced the effects of the Raynaud Phenomenon and the pain. Article Published Date : Jan 01, 2010

Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. 📎

Abstract Title: Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Abstract Source: J Urol. 2009 Aug;182(2):570-80. Epub 2009 Jun 17. PMID: 19535099 Abstract Author(s): Mary P FitzGerald, Rodney U Anderson, Jeannette Potts, Christopher K Payne, Kenneth M Peters, J Quentin Clemens, Rhonda Kotarinos, Laura Fraser, Annemarie Cosby, Carole Fortman, Cynthia Neville, Suzanne Badillo, Lisa Odabachian, Andrea Sanfield, Betsy O'Dougherty, Rick Halle-Podell, Liyi Cen, Shannon Chuai, J Richard Landis, Keith Mickelberg, Ted Barrell, John W Kusek, Leroy M Nyberg, Abstract: PURPOSE: We determined the feasibility of conducting a randomized clinical trial designed to compare 2 methods of manual therapy (myofascial physical therapy and global therapeutic massage) in patients with urological chronic pelvic pain syndromes. MATERIALS AND METHODS: We recruited 48 subjects with chronic prostatitis/chronic pelvic pain syndrome or interstitial cystitis/painful bladder syndrome at 6 clinical centers. Eligible patients were randomized to myofascial physical therapy or global therapeutic massage and were scheduled to receive up to 10 weekly treatments of 1 hour each. Criteria to assess feasibility included adherence of therapists to prescribed therapeutic protocol as determined by records of treatment, adverse events during study treatment and rate of response to therapy as assessed by the patient global response assessment. Primary outcome analysis compared response rates between treatment arms using Mantel-Haenszel methods. RESULTS: There were 23 (49%) men and 24 (51%) women randomized during a 6-month period. Of the patients 24 (51%) were randomized to global therapeutic massage, 23 (49%) to myofascial physical therapy and 44 (94%) completed the study. Therapist adherence to the treatment protocols was excellent. The global response assessment response rate of 57% in the myofascial physical therapy group was significantly higher than the rate of 21% in the global therapeutic massage treatment group (p = 0.03). CONCLUSIONS: We judged the feasibility of conducting a full-scale trial of physical therapy methods and the preliminary findings of a beneficial effect of myofascial physical therapy warrants further study. Article Published Date : Aug 01, 2009

Efficacy of myofascial release techniques in the treatment of primary Raynaud's phenomenon.

Abstract Title: Efficacy of myofascial release techniques in the treatment of primary Raynaud's phenomenon. Abstract Source: J Bodyw Mov Ther. 2008 Jul;12(3):274-80. Epub 2008 Mar 5. PMID: 19083682 Abstract Author(s): Anne Walton Abstract: OBJECTIVE: This study investigated whether myofascial release techniques performed on upper body connective tissue could mitigate the frequency, duration or pain intensity associated with primary Raynaud's phenomenon. METHODS: Five treatments were administered over a 3-week treatment period on a 35-year-old female experiencing primary Raynaud's phenomenon for the past 12 years. A log was kept documenting frequency, duration and severity of pain. The myofascial work targeted the upper back, neck and arms according to hypothetical fascial meridian lines. RESULTS: Symptom duration was the one characteristic that showed improvement. After the first treatment, the duration of the subject's vasospastic episodes was reduced by almost half and continued to decrease throughout the 3 weeks of treatments. Neither the frequency or number of affected digits varied significantly from the pre-treatment weeks. CONCLUSIONS: The results suggest that by releasing restricted fascia, myofascial techniques may influence the duration and severity of the vasospastic episodes experienced in primary Raynaud's phenomenon. Article Published Date : Jul 01, 2008
Therapeutic Actions Myofascial Release

NCBI pubmed

Systematic review of transversus abdominis release in complex abdominal wall reconstruction.

Related Articles Systematic review of transversus abdominis release in complex abdominal wall reconstruction. Hernia. 2018 Dec 11;: Authors: Wegdam JA, Thoolen JMM, Nienhuijs SW, de Bouvy N, de Vries Reilingh TS Abstract BACKGROUND: Transversus abdominis release (TAR), as a type of posterior component separation, is a new myofascial release technique in complex ventral hernia repair. TAR preserves rectus muscle innervation, creates an immense retromuscular plane and allows bilaminar ingrowth of the mesh. The place of the TAR within the range of established anterior component separation techniques (CST) is unclear. Aim of this systematic literature review is to estimate the position of the TAR in the scope of ventral hernia repair techniques. METHODS: MEDLINE, Embase, Pubmed and the Cochrane controlled trials register and Science citation index were searched using the following terms: 'posterior component separation', 'transversus abdominis release', 'ventral hernia repair', 'complex abdominal wall reconstruction'. To prevent duplication bias, only studies with a unique cohort of patients who underwent transversus abdominis release for complex abdominal wall reconstruction were eligible. Postoperative complications and recurrences had to be registered adequately. The rate of surgical site occurrences and recurrences of the TAR were compared with those after anterior CST, published earlier in two meta-analyses. RESULTS: Five articles met our strict inclusion criteria, describing 646 TAR patients. Methodological quality per study was good. Mean hernia surface was 509 cm2 and 88% of the hernias were located in the midline. Preoperative risk stratification was distributed in low risk (10%), co-morbid (55%), potentially contaminated (32%) and infected (3%). Pooled calculations demonstrated a mean SSO rate of 15% after TAR (20-35% after anterior CST) and a mean 2-year hernia recurrence rate of 4% (13% after anterior CST). Mean hernia surface was 300 cm2 in anterior component separation studies. CONCLUSION: This review demonstrates that the transversus abdominis release is a good alternative for anterior CST in terms of SSO and recurrence, especially in very large midline ventral hernias. PMID: 30539311 [PubMed - as supplied by publisher]

Comparison of Myofascial Release Techniques on Pectoralis Minor Length, Glenohumeral Total Arc of Motion, and Skin Temperature: A Pilot Study.

Related Articles Comparison of Myofascial Release Techniques on Pectoralis Minor Length, Glenohumeral Total Arc of Motion, and Skin Temperature: A Pilot Study. J Sport Rehabil. 2018 Dec 11;:1-19 Authors: Rivera M, Eberman L, Games K, Powden CJ Abstract CONTEXT:: The pectoralis minor (PM) is an important postural muscle that may benefit from myofascial techniques such as Graston® Technique (GT) and self-myofascial release (SMR). OBJECTIVE:: To examine the effects of GT and SMR on PM length, glenohumeral total arc of motion (TAM), and skin temperature. DESIGN:: Cohort. SETTING:: Laboratory. PARTICIPANTS:: Twenty-six healthy participants (19 females, 7 males, 20.9±2.24 yrs, height=170.52±8.66 cm, weight=72.45±12.32 kg) with PM length restriction participated. INTERVENTIONS:: Participants were randomized to the intervention groups (GT=12, SMR=14). GT and SMR interventions were both applied for a total of 5 minutes during each of the three treatment sessions. MAIN OUTCOME MEASURES:: PM length, TAM, and skin temperature were collected before and after each intervention session (Pre1, Post1, Pre2, Post2, Pre3, Post3) and at 1-week follow-up (follow-up). Separate intervention by time ANOVAs examined differences for each outcomes measure. Bonferroni post hoc analyses were completed when indicated. Significance was set a-priori at p≤0.05. RESULTS:: No significant intervention by time interactions were identified for PM length, TAM, or temperature (p>0.05). No significant intervention main effects were identified for PM length (p>0.05), TAM (p>0.05), or temperature (p>0.05) between the GT or SMR technique groups. Overall time main effects were found for PM length (p=0.024) and temperature (p<0.001). Post Hoc analysis showed a significant increase in PM length for both intervention groups at follow-up (p=0.028) compared to Post2. Further, there were significant increases in temperature at Post1 (p<0.001), Post2 (p=0.008), and Post3 (p<0.001) compared to Pre1; Post2 was increased compared to Pre2 (p=0.003), Pre3 (p<0.001), and follow-up (p=0.007); Post3 increased compared to Pre3 (p=0.007) and follow-up (p=0.007). CONCLUSION:: Serial application of GT and SMR to the pec minor did not result in increases in PM length or TAM. Regardless of intervention, skin temperature increased following each intervention. PMID: 30526261 [PubMed - as supplied by publisher]
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline